Navigation Links
Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results
Date:3/19/2013

ries, net4,32510,924Prepaid expenses and other current assets4,3674,186Total current assets109,314189,635Property and equipment, net2,050833Deferred financing costs, net4,9694,068Restricted cash and other assets2,8732,580Total assets$

119,206$

197,116LIABILITIES AND STOCKHOLDERS' DEFICITCurrent Liabilities:Accounts payable$

3,435$

7,046Deferred revenues580414Warrant liability2,935—Accrued interest3,1504,643Other current liabilities21,51617,962Total current liabilities31,61630,065Convertible notes, net of discount of $25,354 at December 31, 2012 and

 $54,542 at December 31, 201197,087175,458Senior secured notes, net of discount of $45,114 at December 31, 2012125,827—Other liabilities2,9733Stockholders' Deficit:Preferred stock—$.01 par value 4,000,000 shares authorized; no shares issued——Common stock—$.01 par value 150,000,000 shares authorized; 73,083,000

 issued and outstanding shares at December 31, 2012 and 71,502,000 issued

 and outstanding shares at December 31, 2011731715Additional paid-in-capital397,191408,463Accumulated deficit(535,915)(417,603)Accumulated other comprehensive (loss) income(304)15Total stockholders' deficit(138,297)(8,410)Total liabilities and stockholders' deficit$

119,206$

197,116 

 SAVIENT PHARMACEUTICALS, INC.CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data) Three-Months Ended
December 31,Twelve-Months EndedDecember 31,2012201120122011Revenues:Product sales, net$

4,947$

3,710$

18,023$

9,565Cost and expenses:Cost of goods sold9,7133,30522,3829,313Research and development5,4917,47526,23824,790Selling, general and administrative16,49528,13788,50190,89831,69938,917137,121125,001Operating loss(26,752)(35,207)(119,098)(115,436)Investment income, net3943164150Interest expense on debt(6,930)(4,515)(23,892)(16,357)Gain on extinguishment of
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Savient Pharmaceuticals Reports Second Quarter 2012 Financial Results
2. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
3. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
4. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
5. Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
6. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
7. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
8. AVANIR Pharmaceuticals To participate in two conferences in March
9. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
10. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
11. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , August 28, 2015 ... Product (Media, Sera, Cryogenic Storage Systems, Thawing Equipment, Alarms), ... Regenerative Medicine, Clinical Trials), End User - Global Forecast ... is expected to reach USD 3,731.03 Million by 2020 ... CAGR of 11.65% between 2015 and 2020. ...
(Date:8/28/2015)... NY (PRWEB) , ... August 28, 2015 , ... Since the initial launch of FireflySci ... their quirky humor and excellent customer service. Images such as the Fonz in a ... to add some flavor to the humdrum spectroscopy field. , FireflySci is proud ...
(Date:8/27/2015)... Aug. 27, 2015 The National Necrotizing ... eyes—and life—were saved by doctors at Vanderbilt University Hospital ... NNFF, NovaBay Pharmaceuticals and Dr. John Crew , ... at Seton Medical Center in Daly City, ... a breakthrough approach, pioneered by Dr. Crew, that had ...
(Date:8/27/2015)... ... , ... Inc. Magazine released its annual list of the 5,000 fastest-growing privately ... for the three years through 2014. Being named to the Inc. 5000 list designates ... country. , “We are thrilled to make the Inc. 5000 list for 2015,” ...
Breaking Biology Technology:Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3
... its Construction Unit, aims to increase the efficiency, reduce ... solutions for contaminated sites and for building development itself. ... and currently scientific work is being undertaken which shows ... for the recovery of contaminated soils. At present the ...
... Corporation (Nasdaq: DNDN ) today announced the ... the impact of labeled and unlabeled use of PROVENGE® ... prostate cancer. This panel was convened as a part ... by the Centers for Medicare and Medicaid Services (CMS). ...
... Session ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
Cached Biology Technology:Dendreon Announces MEDCAC Panel Reviewed PROVENGE Evidence 2Dendreon Announces MEDCAC Panel Reviewed PROVENGE Evidence 3Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 2Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 3Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 4Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 5Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 6Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 7Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 8Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 9Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 10
(Date:7/31/2015)... -- Die 10. internationale Konferenz zu Genomik (ICG-10, ... findet vom 22. bis 25. Oktober 2015 in ... Die Konferenz feiert in diesem Jahr ... die ICG weltweit zu einem der einflussreichsten jährlichen ... der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen Zusammentreffen. ...
(Date:7/31/2015)... 31, 2015 The 10 th International Conference ... BGI from October 22-25, 2015, in Shenzhen , ... is celebrating its 10 th anniversary this year. Since its ... most influential annual meetings in the ,omics, fields, and is ... ICG-10 focuses on recent breakthroughs and advances ...
(Date:7/27/2015)... July 27, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Huawei has selected the ... for its stylish smartwatch. Huawei chose the state-of-the-art ... low power and highly responsive human interface qualities ... designers also required a classic round watch face ...
Breaking Biology News(10 mins):Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... climate change causes changes in the species composition of ... also to fish populations. Previous studies demonstrating a link ... entirely on statistical data. However, in order to estimate ... understanding of the effect of water temperature on the ...
... Researchers have made a breakthrough by detecting the electrical ... takes them a step closer to both seeing the ... test drugs. , To stay alive, individual biological ... their cell membranes. This flow produces an electrical current ...
... a major risk factor for Alzheimer's disease puts out the welcome ... to be more active in the brain compared to other forms ... Neurobiology of Aging, add some scientific heft to the idea, long ... bringing about Alzheimer's disease. , The work links a form of ...
Cached Biology News:How fish species suffer as a result of warmer waters 2A new study of living cells could revolutionize the way we test drugs 2Cold sore virus might play role in Alzheimer's disease 2Cold sore virus might play role in Alzheimer's disease 3Cold sore virus might play role in Alzheimer's disease 4
See product name for description....
... excluding l-[U-14C]methionine, 1.85 MBq, 50 uCi. ... > 1.85 GBq/mg atom carbon, ... Mixture of Ala, Arg, Asp, Glu, ... Pro, Ser, Thr, Tyr and Val.1.85 ...
Request Info...
The Proteome Profiler Human Phospho-MAPK Array Kit contains 4 membranes - each spotted in duplicate with 23 different MAPK antibodies....
Biology Products: